Subscribe To
Fxpro enters the fighting ring by sponsoring latvian mma fighter
The interest of forex and contracts for differences (CFDs) brokers in the sport of fighting has tremendously increased. FxPro, an established retail b...
August 1, 2023, 8:04 am
Bicycle therapeutics: decent upside opportunity, mid-stage data readouts due
Bicycle Therapeutics is an intriguing play in the drug development space. Using its fully synthetic short peptides, the company has developed two mid-...
July 31, 2023, 7:07 pm
3 stocks that stand to get crushed by hollywood strikes
On May 2, the Writers Guild of America went on strike against the Alliance of Motion Picture and Television Producers (AMPTP) due to labor disputes pr...
July 31, 2023, 3:25 pm
The latest metaverse trends surrounding nft art galleries
The metaverse has grown as an enthralling and immersive digital universe, providing limitless opportunities for producers, investors, and art enthusia...
July 31, 2023, 1:29 pm
The fight over a bill targeting credit card fees pits payment companies against retailers
Bipartisan support for the Credit Card Competition Act has surged since it was introduced last year....
July 30, 2023, 9:56 am
Tg therapeutics: addressing the sc ocrevus concern
The launch of Briumvi is off to a solid start, but the stock pulled back recently and fell more after Roche reported positive phase 3 results of subcu...
July 29, 2023, 9:50 pm
When art meets philanthropy: gofundme campaigns supporting creative projects
Passion and vision are often fuels for the drive to bring ambitious projects to reality in the realm of art and creativity. However, funding these pur...
July 28, 2023, 12:51 pm
Worthington industries: still a fantastic steel play as infrastructure investments increase
Worthington Industries Inc reported strong Q4 2023 results with net earnings YoY up significantly, reaching $129 million and an EPS of $2.61. The comp...
July 28, 2023, 3:35 am
Nasp thanks the senate finance committee for taking initial steps to address anticompetitive pbm practices
Urges the Committee to Do More to Support Specialty Pharmacies and Patient Pharmacy Choice Washington, DC, July 27, 2023 (GLOBE NEWSWIRE) — The Nati...
July 27, 2023, 3:33 pm
2 stocks that raised their guidance in july
Many of Novartis' top drugs saw their revenue generation grow by double digits this year. PepsiCo did n...
July 26, 2023, 10:01 am
First solar: peg ratio insanely low, buy while you can
First Solar is rated a Buy due to rising growth on a low P/E ratio, with the best ROI for solar panel owners due to efficiency, durability and lifespa...
July 24, 2023, 4:43 pm
Adidas made more than $560 million off unsold yeezy's, report says
Demand for the shoes, designed by Kanye West, appears to outweigh the controversy surrounding the artis...
July 24, 2023, 11:58 am
Novartis ag to spin-off sandoz business in 4q23
Deal Overview On July 18, 2023, Novartis AG (NYSE: NVS, $105.01, Market Capitalization $239....
July 24, 2023, 11:13 am
Should income investors buy this blue chip stock?
Novartis' exceptional lineup of medicines produced stellar results in Q2. The company's market-beating ...
July 23, 2023, 8:30 am
Diving into day one biopharmaceuticals
Shares of precision oncology concern Day One Biopharmaceuticals, Inc. are down over 50% from their 2023 high as Nov...
July 23, 2023, 4:43 am
New book ‘the singers talk’ features interviews with historic roster of artists
On September 5, Permuted Press will publish “The Singers Talk,” a new book featuring interviews with an historic roster of ...
July 22, 2023, 12:00 pm
Dr. dre explains why he ‘bowed out’ of working with michael jackson, prince & stevie wonder
During a conversation with for Season 3, Episode 3 of the “Heart to Hart” podcast, revealed the reason for turning down opportunities to work with...
July 21, 2023, 9:00 pm
Kennedy’s bitcoin plan: a sign bitcoin is becoming mainstream, nonpartisan
Presidential Candidate Robert F. Kennedy Jr unveiled a plan this week to back the US Dollar with bitcoin and eliminate capital gains taxes. Read Full ...
July 21, 2023, 3:14 am
Japan's daiichi sankyo gets us fda nod for blood cancer treatment
The U.S. Food and Drug Administration (FDA) approved Japan-based Daiichi Sankyo Co's treatment for newly diagnosed patients with an aggressive type of...
July 20, 2023, 5:26 pm
Can novartis move to new highs and sustain them?
After more than a decade of trading within a wide and volatile range, it looks like Novartis NYSE: NVS...
July 19, 2023, 7:11 am